Abstract P6-12-02: SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer
Aftimos, P van Herpen, C Mommers, E Koper, N Goedings, P Oesterholt, M Awada, A Desar, I Lim, J Dean, Emma J
Aftimos, P
van Herpen, C
Mommers, E
Koper, N
Goedings, P
Oesterholt, M
Awada, A
Desar, I
Lim, J
Dean, Emma J
Citations
Altmetric:
Abstract
Description
Date
2017-02-14
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Abstract P6-12-02: SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer 2017, 77 (4 Supplement):P6-12-02 Cancer Research